Foods fortified with phytosterins: Their role in decreasing the cholesterol level in serum, their Community authorization and requirements for placing them to the market;Fitoszterinekkel dúsított élelmiszerek: szerepük a szérumkoleszterin-szint csökkentésében, európai közösségi engedélyezésük, piacra kerülésük feltételei

Orvosi Hetilap

Volumn 150, Issue 11, 2009, Pages 483-496

  Lugasi, Andrea ^a,b  

^a Orszagos Gyogyszereszeti Intezet   (Hungary)

^b NONE   (Hungary)

Author keywords

Cardiovascular disease; Health claim for reduced risk of disease; Hypercholesterolaemia; Lipoproteins; Metabolism; Novel food regulation; Phytosterols; Sitosterolemia

Indexed keywords

CAMPESTEROL; CAROTENOID; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; SITOSTEROL; STIGMASTEROL; VEGETABLE OIL;

ARTICLE; AUTHORITY; BILLING AND CLAIMS; CHOLESTEROL BLOOD LEVEL; COMMUNITY; CONSUMER; DIET SUPPLEMENTATION; DIETARY INTAKE; EUROPE; FOOD; FOOD INTAKE; FOOD SAFETY; FRUIT; GRAIN; HEALTH SURVEY; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; LAW; MARKET; NUT; NUTRITIONAL REQUIREMENT; PLANT SEED; RISK FACTOR; RISK REDUCTION; VEGETABLE;

CAROTENOIDS; CHOLESTEROL, LDL; CONSUMER PRODUCT SAFETY; EUROPEAN UNION; FOOD LABELING; FOOD, FORTIFIED; HUMANS; LEGISLATION, FOOD; PHYTOSTEROLS;

EID: 67649213574     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28572     Document Type: Article

References (102)

1. Hartmann, M. A.: Plant sterols and the membrane environment. Trends Plants Sci., 1998, 3, 170-175.
2. Ostlund, R. E.: Phytosterols in human nutrition. Ann. Rev. Nutr., 2002, 22, 533-549.
3. Brufau, G., Canela, M. A., Rafecas, M.: Phytosterols: physiologic and metabolic aspects related to cholesterol-lowering properties. Nutr. Res., 2008, 28, 217-225.
4. Lorentz, R. T., Haeckler, K., Fenner, G.: Analysis of steryl esters. In: Analysis of sterols and other biologically signifi cant steroids. Szerk.: Nes, W. D., Parish, E. J. Academic Press Inc., San Diego, 1989, 33-48.
5. Normén, L.: Phytosterols - effects of intake on cholesterol absorption and colorectal cancer risk. PhD thesis. Department of Clinical Nutrition, Göteborg University, Göteborg, Sweden, 2001.
6. Nguyen, T. T.: The cholesterol-lowering action of plant stanol esters. J. Nutr., 1999, 129, 2109-2112.
7. Gylling, H., Miettinen, T. A.: LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Nutr. Metab. Cardiovasc. Dis., 2002, 12, 19-23.
8. Gylling, H., Miettinen, T. A.: Plant sterols in nutrition - promise or threat for the future. Scand. J. Nutr., 2000, 44, 104S.
9. Moreau, R. A., Whitaker, B. D., Hicks, K. B.: Phytosterols, phytostanols and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses. Prog. Lipid Res., 2002, 41, 457-500.
10. Piironen, V., Lindsay, D. G., Miettinen, T. A. és mtsai: Plant sterols: biosynthesis, biological function and their importance to human nutrition. J. Sci. Food Agric., 2000, 80, 939-966.
11. Klingberg, S., Andersson, H., Mulligan, A. és mtsai: Food sources of plant sterols in the EPIC Norfolk population. Eur. J. Clin. Nutr., 2008, 62, 695-703.
12. Lagarda, M. J., García-Llatas, G., Farré, R.: Analysis of phytosterols in foods. Review. J. Pharmaceut. Biomed. Anal., 2006, 41, 1486-1496.
13. Normen, L., Bryngelsson, S., Johnsson, M. és mtsai: The phytosterol content of some cereal foods commonly consumed in Sweden and in the Netherlands. J. Food Compos. Anal., 2002, 15, 693-704.
14. Normen, L., Johnsson, M., Andersson, H. és mtsai: Plant sterols in vegetables and fruits commonly consumed in Sweden. Eur. J. Nutr., 1999, 38, 84-89.
15. Phillips, K. M., Ruggio, D. M., Toivo, J. I. és mtsai: Free and esterifi ed sterol composition of edible oils and fats. J. Food Compos. Anal., 2002, 15, 123-142.
16. Moghadasian, M. H.: Pharmacological properties of plant ster-ols - in vivo and in vitro observations. Life Sci., 2000, 67, 605-615.
17. Salen, G., Ahrens, E. H., Grundy, S. M.: Metabolism of beta-sitosterol in man. J. Clin. Invest., 1970, 49, 952-967.
18. Kudchodkar, B. J., Sodhi, H. S., Horlick, L.: Absorption of dietary cholesterol in man. Metabolism, 1973, 22, 155-163.
19. Von Bergmann, K., Sudhop, T., Lütjohann, D.: Cholesterol and plant sterol absorption: recent insights. Am. J. Cardiol., 2005, 6, 10D-14D.
20. Heinemann, T., Axtmann, G., von Bergmann, K.: Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur. J. Clin. Invest., 1993, 23, 827-831.
21. Scientifi c Committee on Food: General view on the long-term effects of the intake of elevated levels of phytosterols from multiple dietary sources with particular attention to the effects on β-carotene. Opinion adopted by the Scientifi c Committee on Food on 26 September, 2002. Available online at: http:// ec.europa.eu/food/fs/sc/scf/out143-en.pdf.
22. Morton, G. M., Lee, S. M., Buss, D. H. és mtsa: Intakes and major dietary sources of cholesterol and phytosterols in the British diet. J. Hum. Nutr. Diet, 1995, 8, 429-440.
23. Poulsen, M.: Noforisk - Quantitative risk assessment strategies for novel foods. 3rd Periodic Activity Report, National Food Institute, Technical University, Denmark, 2007, 150-156.
24. Valsta, L. M., Lemström, A., Ovaskainen, M. L. és mtsai: Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake. Br. J. Nutr., 2004, 92, 671-678.
25. Jekel, A. A., Vaessen, H. A. M. G., Schothorst, R. C.: Capillary gas-chromatographic method for determining non-derivatized sterols - some results for duplicate 24 h diet samples collected in 1994. Fresen. J. Anal. Chem., 1998, 360, 595-600.
26. Normén, A. L., Brants, H. A., Voorrips, L. E. és mtsai: Plant sterol intakes and colorectal cancer risk in the Netherlands. Cohort Study on Diet and Cancer. Am. J. Clin. Nutr., 2001, 74, 141-148.
27. Bosner, M. S., Lange, L. G., Stenson, W. F. és mtsa: Percent cholesterol absorption in normal women and men quantifi ed with dual stable isotopic tracers and negative ion mass spectrometry. J. Lipid Res., 1999, 40, 302-308.
28. Ostlund, R. E., McGill, J. B., Zeng, C. M. és mtsai: Gastrointestinal absorption and plasma kinetics of soy delta(5)-phytosterols and phytostanols in humans. Am. J. Physiol. Endocrinol. Me-tab., 2002, 282, E911-E916.
29. Rodler I., Bíró L., Greiner E. és mtsai: Táplálkozási vizsgálat Magyarországon. Orv. Hetil., 2005, 146, 1781-1789.
30. Peterson, D. W.: Plant sterols and tissue cholesterol levels. Am. J. Clin. Nutr., 1958, 6, 644-649.
31. Lees, A. M., Mok, H. Y., Lees, R. S. és mtsai: Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis, 1977, 28, 325-338.
32. Mensink, R. P., Ebbing, S., Lindhout, M. és mtsai: Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis, 2002, 160, 205-213.
33. Miettinen, T. A., Puska, P., Gylling, H. és mtsai: Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N. Engl. J. Med., 1995, 333, 1308-1312.
34. Miettinen, T. A., Vuoristo, M., Nissinen, M. és mtsai: Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am. J. Clin. Nutr., 2000, 71, 1095-1102.
35. Plat, J., van Onselen, E. N., van Heugten, M. M. és mtsa: Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur. J. Clin. Nutr., 2000, 54, 671-677.
36. Hayes, K. C., Pronczuc, A., Perlman, D.: Nonesterifi ed phytosterols dissolved and recrystallized in oil reduce plasma cholesterol in gerbils and humans. J. Nutr., 2004, 134, 1395-1399.
37. Vanstone, C. A., Raeini-Sarjaz, M., Parsons, W. E. és mtsa: Unesterifi ed plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am. J. Clin. Nutr., 2002, 76, 1272-1278.
38. Katan, M. B., Grundy, S. M., Jones, P. és mtsai: Effi cacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc., 2003, 78, 965-978.
39. Grundy, S. M.: Absorption, metabolism of dietary cholesterol. Ann. Rev. Nutr., 1983, 3, 71-96.
40. Normen, L., Dutta, P., Lia, A. és mtsa: Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. Am. J. Clin. Nutr., 2000, 71, 908-913.
41. Blair, S. N., Capuzzi, D. M., Gottlieb, S. O. és mtsai: Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am. J. Cardiol., 2000, 86, 46-52.
42. Christiansen, L. I., Lahteenmaki, P. L., Mannelin, M. R. és mtsai: Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects. Eur. J. Nutr., 2001, 40, 66-73.
43. Davidson, M. H., Maki, K. C., Umporowicz, D. M. és mtsai: Safety and tolerability of esterifi ed phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J. Am. Coll. Nutr., 2001, 20, 307-319.
44. Devaraj, S., Jialal, I., Vega-Lopez, S.: Plant sterol-fortifi ed orange juice effectively lowers cholesterol levels in mildly hyper-cholesterolemic healthy individuals. Arterioscler. Thromb. Vasc. Biol., 2004, 24, e25-e28.
45. Hallikainen, M. A., Sarkkinen, E. S., Uusitupa, M. I.: Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J. Nutr., 2000, 130, 767-776.
46. Hendriks, H. F., Brink, E. J., Meijer, G. W. és mtsai: Safety of long-term consumption of plant sterol esters-enriched spread. Eur. J. Clin. Nutr., 2003, 57, 681-692.
47. Jauhiainen, T., Salo, P., Niittynen, L. és mtsai: Effects of low-fat hard cheese enriched with plant stanol esters on serum lipids and apolipoprotein B in mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr., 2006, 60, 1253-1257.
48. Tikkanen, M. J., Hogstrom, P., Tuomilehto, J. és mtsai: Effect of a diet based on low-fat foods enriched with nonesterifi ed plant sterols and mineral nutrients on serum cholesterol. Am. J. Cardiol., 2001, 88, 1157-1162.
49. Quilez, J., Rafecas, M., Brufau, G. és mtsai: Bakery products enriched with phytosterol esters, alpha-tocopherol and beta carotene decrease plasma LDL-cholesterol and maintain plasma beta-carotene concentrations in normocholesterolemic men and women. J. Nutr., 2003, 133, 3103-3109.
50. Plat, J., Mensink, R. P.: Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. FASEB J., 2002, 16, 1248-1253.
51. Plat, J., Nichols, J. A., Mensink, R. P.: Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J. Lipid Res., 2005, 46, 2468-2476.
52. Trautwein, E. A., Duchateau, G. S., Lin, Y. és mtsai: Proposed mechanisms of cholesterol-lowering action of plant sterols. Eur. J. Lipid Sci. Technol., 2003, 105, 171-185.
53. Altmann, S. W., Davis, H. R., Zhu, L. J. és mtsai: Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science, 2004, 303, 1201-1204.
54. Calpe-Berdiel, L., Escola-Gil, J. C., Ribas, V. és mtsai: Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet. Atherosclerosis, 2005, 181, 75-85.
55. Plosch, T., Kruit, J. K., Huijkman, N. C. és mtsai: Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the abcg5/8 transporter. J. Nutr., 2006, 136, 2135-2140.
56. Rodwell, V. W., Nordstrom, J. L., Mitschelen, J. J.: Regulation of HMGCoA reductase. Adv. Lipid Res., 1976, 14, 1-74.
57. Lau, V. W. Y., Journoud, M., Jones, P. J. H.: Plant sterols are ef-fi cacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons. Am. J. Clin. Nutr., 2005, 81, 1351-1358.
58. Amundsen, A. L., Ntanios, F., Put, N. és mtsa: Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur. J. Clin. Nutr., 2004, 58, 1612-1620.
59. Micallef, M. A., Garg, M. L.: The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J. Nutr., 2008, 138, 1086-1090.
60. Nigon, F., Serfaty-Lacrosnière, C., Beucler, I. és mtsai: Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fi brate treatment. Clin. Chem. Lab. Med., 2001, 39, 634-640.
61. Baker, V. A., Hepburn, P. A., Kennedy, S. J. és mtsai: Safety evaluation of phytosterol esters: Part 1. Assessment of oestrogenic- ity using a combination of in vivo and in vitro assays. Food Chem. Toxicol., 1999, 37, 13-22.
62. Hepburn, P. A., Horner, S. A., Smith, M.: Safety evaluation of phytosterol esters: Part 2. Subchronic 90-day oral toxicity on phytosterol esters - a novel functional food. Food Chem. Toxicol., 1999, 37, 521-532.
63. Waalkens-Berendsen, D. H., Wolterbeek, A. P., Wijnands, M. V. és mtsai: Safety evaluation of phytosterol esters: Part 3. Two generation reproduction study in rats with phytosterol esters: a novel functional food. Food Chem. Toxicol., 1999, 37, 683-696.
64. Ayesh, R., Weststrate, J. A., Drewitt, P. N. és mtsa: Safety evaluation of phytosterol esters: Part 5. Faecal short-chain fatty acid and microfl ora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without phytosterol ester-enriched margarine. Food Chem. Toxicol., 1999, 37, 1127-1138.
65. Weststrate, J. A., Ayesh, R., Blauer-Plank, C. és mtsa: Safety evaluation of phytosterol esters: Part 4. Faecal concentrations of bile acids and neutral sterols in healthy normolipaedemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food Chem. Toxicol., 1999, 37, 1063-1071.
66. De Jong, N., Pijpers, L., Bleeker, J. K. és mtsa: Potential intake of phytosterols/-stanols: results of a simulation study. Eur. J. Clin. Nutr., 2004, 58, 907-919.
67. Turnbull, D., Frankos, V. H., van Delft, J. H. és mtsa: Genotoxicity evaluation of wood-derived and vegetable oil-derived stanol esters. Regul. Toxicol. Pharmacol., 1999, 29, 205-210.
68. Berger, A., Jones, P. J. H., Abumweis, S. S.: Plant sterols: factors affecting their effi cacy and safety as functional food ingredients. Lipids Health Dis., 2004, 3, 5.
69. Hallikainen, M. A., Sarkkinen, E. S., Uusitupa, M. I. J.: Effects of low-fat stanol ester enriched margarine on concentrations of serum carotenoids in subjects with elevated serum cholesterol concentrations. Eur. J. Clin. Nutr., 1999, 53, 966-969.
70. Weststrate, J. A., Meijer, G. W.: Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr., 1998, 52, 334-343.
71. Judd, J. T., Baer, D. J., Chen, S. C. és mtsai: Plant sterol esters lower plasma lipids and most carotenoids in mildly hypercholesterolemic adults. Lipids, 2002, 37, 33-42.
72. Law, M.: Plant sterol and stanol margarines and health. BMJ, 2000, 320, 861-864.
73. Noakes, M., Clifton, P., Ntanios, F. és mtsai: An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am. J. Clin. Nutr., 2002, 75, 79-86.
74. Scientifi c Committee on Food: Opinion applications for approval of a variety of plant sterol-enriched foods. Opinion adopted by the Scientifi c Committee on Food on 5 March, 2003. Available online at: http://ec.europa.eu/ food/fs/sc/scf/out174-en.pdf.
75. Bhattacharyya, A. K., Connor, W. E.: Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J. Clin. Invest., 1974, 53, 1033-1043.
76. Salen, G., Kwiterovich, P. O., Shefer, S. és mtsai: Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. J. Lipid Res., 1985, 26, 203-209.
77. Watts, G. F., Mitchell, W. D.: Clinical and metabolic fi ndings in a patient with phytosterolaemia. Ann. Clin. Biochem., 1992, 29, Part 2.
78. Salen, G., Shefer, S., Nguyen, L. és mtsai: Sitosterolemia. J. Lipid Res., 1992, 33, 945-955.
79. Miettinen, T. A.: Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur. J. Clin. Invest., 1980, 10, 27-35.
80. Lütjohann, D., Bjorkhem, I., Beil, U. F. és mtsa: Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J. Lipid Res., 1995, 36, 1763-1773.
81. Berge, K. E., von Bergmann, K., Lutjohann, D. és mtsai: Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res., 2002, 43, 486-494.
82. Lu, K., Lee, M. H., Hazard, S. és mtsai: Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am. J. Hum. Genet., 2001, 69, 278-290.
83. Lizard, G.: Phytosterols: to be or not to be toxic; that is the question. Br. J. Nutr., 2008, 100, 1150-1151.
84. Rubins, B., Paszel, A., Kaczmarek, M. és mtsai: Benefi cial or harmful infl uence of phytosterols on human cells? Br. J. Nutr., 2008, 100, 1183-1191.
85. Salen, G., Horak, I., Rothkopf, M. és mtsai: Lethal atherosclerosis associated with abnormal plasma and tissue steroid composition and sitosterolemia with xanthomatosis. J. Lipid Res., 1985a, 26, 1126-1133.
86. Patel, M. D., Thompson, P. D.: Phytosterols and vascular disease. Atherosclerosis, 2006, 186, 12-19.
87. EFSA Report from the Data Collection and Exposure Unit in response to a request from the European Commission: Consumption of food and beverages with added plant sterols in the European Union. EFSA J., 2008a, 133, 1-21.
88. International Atherosclerosis Society: Harmonized clinical guidelines on the prevention of atherosclerotic vascular disease. International Atherosclerosis Society, Hamburg, Germany, 2003, 1-28.
89. NCEP: Expert panel on detection evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497.
90. National Heart Foundation: Lipid management guidelines -2001. Med. J. Aust., 2001, 175, S1-36.
91. National Heart Foundation of Australia: Summary of the evidence on phytosterols/stanol enriched foods. 2007, available at: http://www. heartfoundation.org.au/document/NHF/ HF-Phytosterols-Stanols-Summ of Evidence-2007-Aug-FI-NAL.pdf.
92. National Heart Foundation of Australia: Plant sterols and stanols. A position statement from the National Heart Foundation of Australia's Nutrition and Metabolism Advisory Committee. NHFA, 2003, available at: www.heartfoundation. org.au.
93. National Health and Medical Research Council: A guide to the development, implementation and evaluation of clinical practice guidelines. Canberra, NHMRC, 1999.
94. Commission, Regulation 258/97/EC of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients. Off. J. Eur. Comm., L 43, 1997, 1-7.
95. Lugasi A.: Új élelmiszerek engedélyezé se az Európai Unió 258/97/EK rendeletében foglaltak szerint. A HÚS, 2006, 16, 33-35.
96. Lugasi A.: Az új élelmiszerek engedé lyezése és a noni (Morinda citrifolia L.) jelenlegi helyzete. Közinfó, 2005, 8, 22-27.
97. Commission Decision 2000/500/EC on authorising the placing on the market of "yellow fat spreads with added phytosterol esters" as a novel food or novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council. Off. J. Eur. Comm., L 200, 2000, 59-60.
98. Commission Regulation 608/2004/EC concerning the labelling of foods and food ingredients with added phytosterols, phytosterol esters, phytostanols and/or phytostanol esters. Off. J. Eur. Comm., L97, 2004, 44-45.
99. Anon. Strategic analysis of the European phytosterols market. Market Report. Frost & Sullivan Research Service, London, United Kingdom, 2006.
100. Commission Regulation 1924/2006/EC of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Off. J. Eur. Union, L404, 2006, Corrigendum Off. J. Eur. Union L12, 2007, 3-18.
101. EFSA Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from Unilever PLC/NV on Plant Sterols and lower/reduced blood cholesterol, reduced the risk of (coronary) heart disease. EFSA J., 2008b, 781, 1-12.
102. EFSA Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from McNeil Nutritionals Ltd. related to the scientifi c substantiation of a health claim on plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease. EFSA J., 2008c, 825, 1-13.